INS and metabolic dysfunction-associated steatotic liver disease: It has been documented that body weight reduction is a crucial way suggested for type 2 diabetes and NAFLD patients since weight loss could decrease hepatic triglyceride accumulation with an improvement of insulin sensitivity [44].